#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13510	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2537	655.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1883	1883	T	895	T,G,A,C	887,5,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13510	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2537	655.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1617	1617	C	876	C,T	875,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13510	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2537	655.5	0	HET	.	.	.	C260T	.	260	260	C	693	693	C	780	C,T	446,334	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13510	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2537	655.5	0	HET	.	.	.	A69G,T	.	69	69	A	502	502	A	832	A,G,T	437,393,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22950	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4038	708.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1912	1912	A	959	A	959	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22950	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4038	708.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2546	2546	C	806	C,T,A	803,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22950	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4038	708.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2620	2620	A	731	A,G	730,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22950	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4038	708.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3172	3172	C	813	C,T,A	809,2,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2086	folP	852	852	99.88	folP.l15.c4.ctg.1	1935	134.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	971	973	AAA	189;188;187	A;A;A	189;188;187	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2086	folP	852	852	99.88	folP.l15.c4.ctg.1	1935	134.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1202	1204	AGC	222;222;221	A;G;C,G	222;222;220,1	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3781	171.5	1	SNP	p	S91F	0	.	.	271	273	TCC	778	780	TCC	206;208;208	T;C,A;C	206;207,1;208	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3781	171.5	1	SNP	p	D95G	0	.	.	283	285	GAC	790	792	GAC	219;220;221	G;A,T;C	219;219,1;221	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5208	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3781	171.5	1	SNP	p	D95N	0	.	.	283	285	GAC	790	792	GAC	219;220;221	G;A,T;C	219;219,1;221	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1808	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1815	124.1	1	SNP	p	G45D	0	.	.	133	135	GGC	756	758	GGC	189;185;185	G;G;C,T	189;185;184,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1010	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1361	92.1	0	.	n	.	0	A197.	DEL	197	197	A	759	759	A	194	A,G	193,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4586	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3531	162.0	1	SNP	p	D86N	0	.	.	256	258	GAC	825	827	GAC	230;232;231	G;A,C;C	230;230,2;231	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4586	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3531	162.0	1	SNP	p	S87I	0	.	.	259	261	AGT	828	830	AGT	231;228;230	A;G,T;T	231;227,1;230	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4586	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3531	162.0	1	SNP	p	S87R	0	.	.	259	261	AGT	828	830	AGT	231;228;230	A;G,T;T	231;227,1;230	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4586	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3531	162.0	1	SNP	p	S87W	0	.	.	259	261	AGT	828	830	AGT	231;228;230	A;G,T;T	231;227,1;230	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4586	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3531	162.0	1	SNP	p	S88P	0	.	.	262	264	TCC	831	833	TCC	236;234;239	T,G,A;C,A;C,A	234,1,1;233,1;238,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3940	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3139	156.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1777	1779	GGC	210;205;205	G;G;C	210;205;205	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1570	1572	GCA	222;220;220	G;C;A	222;220;220	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1573	1575	ATC	218;219;220	A;T,G;C	218;218,1;220	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1585	1587	GTG	210;211;209	G;T,G;G	210;210,1;209	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1585	1587	GTG	210;211;209	G;T,G;G	210;210,1;209	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2089	2091	ACC	208;208;208	A,T;C;C	207,1;208;208	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2143	2145	GCG	208;207;204	G;C,G,A;G,T	208;205,1,1;203,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2143	2145	GCG	208;207;204	G;C,G,A;G,T	208;205,1,1;203,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2266	2268	GGC	220;223;222	G;G,C;C	220;222,1;222	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2275	2277	GGC	223;221;221	G;G,T;C,A	223;220,1;220,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3746	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3031	154.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2293	2295	CTG	218;218;218	C;T;G,A	218;218;217,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5250	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3632	180.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1896	1898	CCG	220;225;221	C;C;G	220;225;221	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2106	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2340	112.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	804	804	C	164	C	164	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	100	94.0	porB1a.l15.c4.ctg.1	182	50.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	56;53;53	A,T;C;G	55,1;53;53	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	100	94.0	porB1a.l15.c4.ctg.1	182	50.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	23;22;17	C;A,C;A	23;21,1;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	41.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	13	15	TTA	20;22;22	T;T;A	20;22;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	41.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	58	60	CAT	51;51;51	C;A;T	51;51;51	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	41.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	61	63	AGT	51;51;51	A;G;T	51;51;51	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	272	porB1a	984	152	93.42	porB1a.l15.c4.ctg.4	155	41.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	70	72	TAC	51;51;51	T;A;C	51;51;51	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	730	732	GAA	241;243;242	G,T;A,C;A	240,1;242,1;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1018	1020	GAT	258;250;249	G;A;T	258;250;249	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1141	1143	TCA	231;230;231	T;C;A	231;230;231	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1270	1272	GTC	250;250;248	G;T;C	250;250;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	0	.	p	.	0	E328V	NONSYN	982	984	GAA	1600	1602	GTA	204;204;203	G;T;A,C	204;204;202,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	1	SNP	p	G120K	1	.	.	358	360	AAG	976	978	AAG	240;236;237	A;A,C;G	239;235,1;237	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	1	SNP	p	A121D	1	.	.	361	363	GAC	979	981	GAC	239;241;242	G;A;C	239;241;242	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2738	porB1b	1047	1047	99.33	porB1b.l6.c17.ctg.1	2103	162.1	1	SNP	p	D121N	0	.	.	361	363	GAC	979	981	GAC	239;241;242	G;A;C	239;241;242	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	100	93.0	porB3.l15.c17.ctg.1	177	47.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	128	130	ACG	50;47;47	A,T;C;G	49,1;47;47	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	100	93.0	porB3.l15.c17.ctg.1	177	47.8	0	.	p	.	0	T29A	NONSYN	85	87	ACC	161	163	GCC	39;39;38	G;C;C	39;39;38	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	100	93.0	porB3.l15.c17.ctg.1	177	47.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	170	172	CAA	23;22;17	C;A,C;A	23;21,1;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	V260L	NONSYN	778	780	GTA	13	15	TTA	20;22;22	T;T;A	20;22;22	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	D275H	NONSYN	823	825	GAT	58	60	CAT	54;54;54	C;A;T	54;54;54	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	D276S	NONSYN	826	828	GAT	61	63	AGT	54;54;54	A;G;T	54;54;54	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	K278D	NONSYN	832	834	AAA	67	69	GAC	54;54;54	G;A;C	54;54;54	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	70	72	TAC	54;54;55	T;A;C	54;54;55	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	E309V	NONSYN	925	927	GAA	160	162	GTA	1;1;1	G;T;A	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	E313A	NONSYN	937	939	GAA	172	174	GCA	1;1;1	G;C;A	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	N314D	NONSYN	940	942	AAC	175	177	GAC	1;1;1	G;A;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	F316I	NONSYN	946	948	TTC	181	183	ATC	1;1;1	A;T;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	512	246	porB3	990	192	91.67	porB3.l15.c17.ctg.2	196	35.1	0	.	p	.	0	A318S	NONSYN	952	954	GCG	187	189	TCG	1;1;1	T;C;G	1;1;1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8920	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5339	208.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2236	2238	AAT	223;224;222	A;A;T	223;224;222	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1302	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1520	106.8	1	SNP	p	V57M	1	.	.	169	171	ATG	815	817	ATG	206;206;207	A;T;GAA,GAAA	206;206;201,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
